Atrial Fibrillation Trial, Recruiting NCT05643235 Sponsor: Northwell Health Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05643235
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age
  • People who are willing to sign and date a consent form
  • People who are willing to have their heart monitored remotely
  • People who are about to start a type of cancer treatment called a BTK inhibitor for an approved condition (such as certain blood cancers like CLL or Waldenström's disease)
  • People who are willing to have a small Medtronic heart monitor inserted under the skin for at least 24 hours of continuous heart monitoring before starting the BTK inhibitor treatment

Who may not be able to join:

  • People who have had a diagnosed irregular heart rhythm (atrial fibrillation or ventricular arrhythmia) in the past 12 months
  • People who have had a stroke or mini-stroke (TIA) in the past year
  • People who already have an implanted heart device, such as a pacemaker or defibrillator
  • People who have had heart surgery within the past 90 days
  • People who have had a heart attack within the past 90 days
  • People who are currently taking medication to control heart rhythm or to thin the blood (prevent clotting)
  • People who have another health condition or circumstance (such as substance abuse) that may make safe participation in the study difficult (confirm with trial site)
  • People who are already enrolled in another research study that could affect the results of this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert S Copeland-Halperin, MD, Northwell Health

Phone: 212-434-6614

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northwell Health
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of device detected atrial fibrillation (AF); Long term Incidence of device detected AF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov